# Genomenon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genomenon

- Industry: Software
- Headquarters: Ann Arbor, US
- Website: www.genomenon.com
- Total disclosed funding: $31M
- Latest round: Series B (Feb 24, 2022)
- Investors on record: 17

## About

Genomenon, Inc. is a genomic intelligence company that leverages artificial intelligence to enhance the interpretation of vast genomic datasets, providing critical insights for precision medicine and cancer treatment.Founded in 2014 and headquartered in Ann Arbor, Michigan, Genomenon specializes in genomic data solutions. The firm has undergone significant growth and development in its operations. Notably, the company has raised a total of USD 20.00 mn in a Series B funding round on February 24, 2022, led by investors including Beringea Private Equity and Spring Mountain Capital. The firm was co-founded by Mark Kiel and Steve Schwartz, with Mike Klein serving as the CEO. Genomenon has executed 10 deals to date, positioning itself strategically within the genomic sector.Genomenon offers a suite of genomic data solutions centered around the Mastermind Genomic Intelligence Platform, which utilizes artificial intelligence for analyzing and interpreting extensive genomic datasets. The platform supports rapid search capabilities and insights into genomic literature for both germline and somatic variant interpretation. Additionally, Genomenon provides a Cancer Knowledgebase that assists in interpreting cancer variants by linking them to relevant therapies and clinical trials. Their offerings also include custom variant analysis, clinical trial support, and regulatory guidance for healthcare providers, research institutions, and pharmaceutical companies, primarily across North America, Europe, and select regions in Asia.Genomenon generates revenue through software subscriptions and consulting services. Clients primarily engage with the Mastermind platform on a subscription model, gaining access to advanced genomic analysis features. The company also provides tailored consulting services, often forming long-term partnerships with research institutions and healthcare providers. Their client base includes pharmaceutical companies, diagnostic labs, and health networks, with a pricing structure that reflects the comprehensive nature of their offerings.In February 2022, Genomenon, Inc. raised USD 20.00 mn in Series B funding to further develop its commercial operations. The company plans to leverage this funding to expand its product offerings and enhance its market presence. Upcoming initiatives include the introduction of new features for the Mastermind platform aimed at improving user experience and genomic analysis capabilities. Genomenon is also targeting expansion into additional markets across Europe and Asia, with specific plans for geographic growth to be outlined by the end of 2023.

## Funding rounds

- Series B, Feb 24, 2022, $20M — Beringea, Invest Detroit, Spring Mountain Capital, University of Michigan (Ross School of Business), BroadOak Capital Partners, Atain Insurance Company, Michigan Angel Fund, IrishAngels, Green Park & Golf Ventures, Red Cedar Ventures, Michigan Rise, Riverine Ventures
- Series A, Mar 16, 2021, $5.3M — Invest Detroit, Detroit Venture Partners, BroadOak Capital Partners, Atain Insurance Company, InvestMichigan! Growth Capital Fund, Michigan Angel Fund, IrishAngels, Green Park & Golf Ventures, Red Cedar Ventures, Michigan Rise
- Series A, Oct 19, 2018, $2.5M — Invest Detroit, InvestMichigan! Growth Capital Fund, Michigan Angel Fund, IrishAngels, Michigan Investment in New Technology Startups, H. W. Kaufman Group
- Seed, Nov 10, 2016, $1.8M — Michigan Angel Fund
- Seed, Jan 7, 2016, $0.9M — Invest Detroit, InvestMichigan! Growth Capital Fund, Michigan Angel Fund, Three Leaf Ventures
- Seed, Aug 1, 2015, $0.8M — Michigan Angel Fund

## Investors

- Michigan Angel Fund (https://capitalatlas.ai/funds/michigan-angel-fund) — Seed, Series A, Series B
- Invest Detroit (https://capitalatlas.ai/funds/invest-detroit) — Seed, Series A, Series B
- InvestMichigan! Growth Capital Fund — Seed, Series A
- Three Leaf Ventures (https://capitalatlas.ai/funds/three-leaf-ventures) — Seed
- IrishAngels (https://capitalatlas.ai/funds/irishangels) — Series A, Series B
- Michigan Investment in New Technology Startups (https://capitalatlas.ai/funds/michigan-investment-in-new-technology-startups) — Series A
- H. W. Kaufman Group — Series A
- Detroit Venture Partners (https://capitalatlas.ai/funds/detroit-venture-partners) — Series A
- BroadOak Capital Partners (https://capitalatlas.ai/funds/broadoak-capital-partners) — Series A, Series B
- Atain Insurance Company — Series A, Series B
- Green Park & Golf Ventures (https://capitalatlas.ai/funds/green-park-golf-ventures) — Series A, Series B
- Red Cedar Ventures (https://capitalatlas.ai/funds/red-cedar-ventures) — Series A, Series B
- Michigan Rise (https://capitalatlas.ai/funds/michigan-rise) — Series A, Series B
- Beringea (https://capitalatlas.ai/funds/beringea) — Series B
- Spring Mountain Capital (https://capitalatlas.ai/funds/spring-mountain-capital) — Series B
- University of Michigan (Ross School of Business) (https://capitalatlas.ai/funds/university-of-michigan-ross-school-of-business) — Series B
- Riverine Ventures (https://capitalatlas.ai/funds/riverine-ventures) — Series B